The design of this Japanese vendor's new x-ray angiography systemhas been raising eyebrows since it was featured in a panel displayin the company's booth at the 1994 RSNA meeting. SF-VA 100 isa rotational angiography system, but it looks more like a CT
The design of this Japanese vendor's new x-ray angiography systemhas been raising eyebrows since it was featured in a panel displayin the company's booth at the 1994 RSNA meeting. SF-VA 100 isa rotational angiography system, but it looks more like a CT scanner,due to the gantry that houses the system's x-ray tube and assembly.
Hitachi will finally be able to test the commercial watersfor SF-VA 100 after receiving 510(k) clearance for the productthis summer. SF-VA 100 generates up to 288 views acquired in a360° rotation performed in five seconds. The digitized sequencemay be played back in subtracted or nonsubtracted modes to createa detailed 360° perspective of selected vasculature and surroundingstructures.
In MRI, enhancements for the open-style Airis and 1.5-teslaStratis will be the promotional focal points for Hitachi. Thecompany will highlight version 4.0 software for the 0.3-teslaAiris, which features image display and control panel refinements,improved fast spin-echo imaging, and fast fluid-attenuated inversionrecovery (Fast Flair), a sequence for fluid-suppressed T2-weightedimaging. The Stratis presentation will feature phased-array coilsand echo-planar imaging, according to Sheldon Schaffer, directorof marketing.
The ultrasound section of Hitachi's booth will feature EUB-525,a color-flow scanner. The system has been displayed at previousRSNA meetings, but Hitachi began shipments in August after receivingFDA clearance, according to Patrick Herguth, product manager forthe ultrasound division.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.